It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Heart disease (HD) is a serious widespread life-threatening disease. The heart of patients with HD fails to pump sufficient amounts of blood to the entire body. Diagnosing the occurrence of HD early and efficiently may prevent the manifestation of the debilitating effects of this disease and aid in its effective treatment. Classical methods for diagnosing HD are sometimes unreliable and insufficient in analyzing the related symptoms. As an alternative, noninvasive medical procedures based on machine learning (ML) methods provide reliable HD diagnosis and efficient prediction of HD conditions. However, the existing models of automated ML-based HD diagnostic methods cannot satisfy clinical evaluation criteria because of their inability to recognize anomalies in extracted symptoms represented as classification features from patients with HD. In this study, we propose an automated heart disease diagnosis (AHDD) system that integrates a binary convolutional neural network (CNN) with a new multi-agent feature wrapper (MAFW) model. The MAFW model consists of four software agents that operate a genetic algorithm (GA), a support vector machine (SVM), and Naïve Bayes (NB). The agents instruct the GA to perform a global search on HD features and adjust the weights of SVM and BN during initial classification. A final tuning to CNN is then performed to ensure that the best set of features are included in HD identification. The CNN consists of five layers that categorize patients as healthy or with HD according to the analysis of optimized HD features. We evaluate the classification performance of the proposed AHDD system via 12 common ML techniques and conventional CNN models by using a cross-validation technique and by assessing six evaluation criteria. The AHDD system achieves the highest accuracy of 90.1%, whereas the other ML and conventional CNN models attain only 72.3%–83.8% accuracy on average. Therefore, the AHDD system proposed herein has the highest capability to identify patients with HD. This system can be used by medical practitioners to diagnose HD efficiently.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer